AAAS Newcomb Cleveland Prize
2011 Award Recipients
Supported by Affymetrix
The 2011 Newcomb Cleveland Prize is awarded to Waseem S. Bakr, Amy Peng, M. Eric Tai, Ruichao Ma, Jonathan Simon, Jonathon Isaiah Gillen, Simon Fölling, Lode Pollet, and Markus Greiner for the research article “Probing the Superfluid-to-Mott Insulator Transition at the Single-Atom Level,” published in Science30 July 2010, pp. 547-550.
This paper reports a technical and scientific innovation in the use of ultracold atomic gases to investigate important quantum phase transitions, such as the ones that produce superfluidity. The authors demonstrate the ability to monitor atoms trapped in an optical lattice at the single-site level and reveal the emergence of a specific insulating phase. Their approach will have a tremendous impact on the field of quantum gases.
The Association’s oldest award, the AAAS Newcomb Cleveland Prize, supported by Affymetrix, was established in 1923 with funds donated by Newcomb Cleveland of New York City. The Prize acknowledges an outstanding paper published in the Articles, Research Articles, or Reports sections of Science. Each recipient receives a bronze medal and a share of the $25,000 prize.
Affymetrix Inc. added its support to the AAAS Newcomb Cleveland Prize in 2003, helping to more than double the prize’s monetary value. Affymetrix Founder and Executive Chairman, Stephen P.A. Fodor, Ph.D., and his colleagues were awarded the Newcomb Cleveland Prize in 1991 for their landmark publication that first introduced microarray technology to the scientific community. (“Light-directed, spatially addressable parallel chemical synthesis,” with co-authors J. Read, M.C. Pirrung, L. Stryer, A. Lu, and D. Solas, Science 15 February 1991.)
“Receiving the Newcomb Cleveland Award in 1991 was the first important public acknowledgment of our invention,” said Fodor. “Today, the award remains one of our most valued. Affymetrix is thrilled to support its continued legacy. It is important to recognize and encourage the innovative work of new scientists as their work will become the foundation for future research and discovery.”
Affymetrix is a pioneer in creating breakthrough tools that are driving the genomic revolution. By applying the principles of semiconductor technology to the life sciences, Affymetrix develops and commercializes systems that enable scientists to improve quality of life. The company’s customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies as well as academic, government, and non-profit research institutes. Affymetrix offers an expanding portfolio of integrated products and services to address growing markets focused on understanding the relationship between genes and human health. Affymetrix has about 1,000 employees worldwide.